KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Current Assets (2016 - 2025)

Historic Current Assets for BeOne Medicines (ONC) over the last 11 years, with Q3 2025 value amounting to $5.7 billion.

  • BeOne Medicines' Current Assets rose 4480.72% to $5.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 billion, marking a year-over-year increase of 4480.72%. This contributed to the annual value of $4.0 billion for FY2024, which is 503.93% down from last year.
  • According to the latest figures from Q3 2025, BeOne Medicines' Current Assets is $5.7 billion, which was up 4480.72% from $4.3 billion recorded in Q2 2025.
  • In the past 5 years, BeOne Medicines' Current Assets ranged from a high of $7.6 billion in Q4 2021 and a low of $3.1 billion during Q4 2022
  • Moreover, its 5-year median value for Current Assets was $4.4 billion (2023), whereas its average is $4.8 billion.
  • As far as peak fluctuations go, BeOne Medicines' Current Assets surged by 5348.43% in 2021, and later crashed by 5932.93% in 2022.
  • Over the past 5 years, BeOne Medicines' Current Assets (Quarter) stood at $7.6 billion in 2021, then plummeted by 59.33% to $3.1 billion in 2022, then skyrocketed by 35.74% to $4.2 billion in 2023, then decreased by 5.04% to $4.0 billion in 2024, then surged by 41.91% to $5.7 billion in 2025.
  • Its Current Assets stands at $5.7 billion for Q3 2025, versus $4.3 billion for Q2 2025 and $3.9 billion for Q1 2025.